Structure of the Catalytic Domain of Human Polo-like Kinase 1,-Reference-Cited by-同舟云学术

Structure of the Catalytic Domain of Human Polo-like Kinase 1,

Published:2007-04-27 Issue:20 Volume:46 Page:5960-5971
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Kothe Michael¹,Kohls Darcy¹,Low Simon¹,Coli Rocco¹,Cheng Alan C.¹,Jacques Suzanne L.¹,Johnson Theresa L.¹,Lewis Cristina¹,Loh Christine¹,Nonomiya Jim¹,Sheils Alissa L.¹,Verdries Kimberly A.¹,Wynn Thomas A.¹,Kuhn Cyrille¹,Ding Yuan-Hua¹

Affiliation:

1. Pfizer Global Research and Development, Research Technology Center, 620 Memorial Drive, Cambridge, Massachusetts 02139, and Pfizer Global Research and Development, La Jolla Laboratories, La Jolla California 92121

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi602474j

Reference56 articles.

1. Targeting polo-like kinase 1 for cancer therapy

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crystal Structures of Plk1 Polo-Box Domain Bound to the Human Papillomavirus Minor Capsid Protein L2-Derived Peptide;Journal of Microbiology;2023-08

2. Anticancer Activity of Anti-Tubercular Compound(s) Designed on Pyrrolyl Benzohydrazine Scaffolds: A Repurposing Study;Processes;2023-06-23

3. The flavonoid hesperidin methyl chalcone as a potential therapeutic agent for cancer therapy: Molecular docking, in vitro cytotoxicity, and in vivo antitumor activity;Arabian Journal of Chemistry;2023-06

4. The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors;Cells;2023-05-08

5. Design and Synthesis of Aminopyrimidinyl Pyrazole Analogs as PLK1 Inhibitors Using Hybrid 3D-QSAR and Molecular Docking;Pharmaceuticals;2022-09-21